Denali Therapeutics, Inc. (DNLI)
24.53
-0.40
(-1.60%)
USD |
NASDAQ |
Aug 26, 10:51
Denali Therapeutics 1 Year Total Returns (Daily) : 60.12% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 60.12% |
| August 24, 2026 | 56.23% |
| August 21, 2026 | 63.62% |
| August 20, 2026 | 71.95% |
| August 19, 2026 | 73.52% |
| August 18, 2026 | 64.04% |
| August 17, 2026 | 65.65% |
| August 14, 2026 | 68.74% |
| August 13, 2026 | 67.59% |
| August 12, 2026 | 91.15% |
| August 11, 2026 | 77.37% |
| August 10, 2026 | 79.08% |
| August 07, 2026 | 74.49% |
| August 06, 2026 | 72.33% |
| August 05, 2026 | 70.89% |
| August 04, 2026 | 67.38% |
| August 03, 2026 | 72.25% |
| July 31, 2026 | 66.45% |
| July 30, 2026 | 78.13% |
| July 29, 2026 | 75.24% |
| July 28, 2026 | 76.45% |
| July 27, 2026 | 72.42% |
| July 24, 2026 | 61.50% |
| July 23, 2026 | 61.85% |
| July 22, 2026 | 70.44% |
| Date | Value |
|---|---|
| July 21, 2026 | 72.31% |
| July 20, 2026 | 63.57% |
| July 17, 2026 | 60.29% |
| July 16, 2026 | 52.86% |
| July 15, 2026 | 62.46% |
| July 14, 2026 | 54.19% |
| July 13, 2026 | 82.37% |
| July 10, 2026 | 67.30% |
| July 09, 2026 | 81.40% |
| July 08, 2026 | 86.25% |
| July 07, 2026 | 84.63% |
| July 06, 2026 | 75.22% |
| July 02, 2026 | 73.36% |
| July 01, 2026 | 86.24% |
| June 30, 2026 | 83.85% |
| June 29, 2026 | 83.62% |
| June 26, 2026 | 76.47% |
| June 25, 2026 | 71.14% |
| June 24, 2026 | 72.36% |
| June 23, 2026 | 81.86% |
| June 22, 2026 | 73.15% |
| June 18, 2026 | 65.44% |
| June 17, 2026 | 67.67% |
| June 16, 2026 | 50.00% |
| June 15, 2026 | 52.71% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 329.2% |
| Biogen, Inc. | 61.90% |
| Oncolytics Biotech, Inc. | -12.88% |
| Sangamo Therapeutics, Inc. | -72.93% |
| Sarepta Therapeutics, Inc. | 4.76% |